logo

For the Inventor, By the Inventor

Brookline, MA, United States of America

Yutaka Ueda

This inventor holds 3 USPTO granted patents. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1997-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yutaka Ueda. Retrieved from https://idiyas.com/inventor/yutaka-ueda-kodnp1wf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 63(Granted Patents)


Location History:

  • Brookline, MA (US) (1997)
  • Toyonaka, JP (1997)
  • Ibaraki, JP (1999)

Company Filing History:

goldMedal3 out of 174 
 
Sumitomo Pharmaceuticals Company Limited
 patents

Years Active: 1997-1999

Loading Chart...
3 patents (USPTO):Explore Patents
1. 5948786 - Piperidinylpyrimidine derivatives (1999-09-07),
2. 5648359 - Tumor necrosis factor production inhibitors (1997-07-15),
3. 5646154 - Pharmaceutical compositions for inhibiting the formation of tumor (1997-07-08),

Title: Yutaka Ueda: Innovator in Pharmaceutical Development

Introduction

Yutaka Ueda is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit tumor necrosis factor production. With a total of 3 patents to his name, Ueda's work has the potential to impact various medical conditions.

Latest Patents

Ueda's latest patents include innovative compounds such as Piperidinylpyrimidine derivatives. This compound is effective for inhibiting the production and/or secretion of tumor necrosis factor in patients requiring such intervention. Another significant patent focuses on compositions for inhibiting tumor necrosis factor production, which can be beneficial in treating conditions like cachexia, septic shock, rheumatoid arthritis, and Type II diabetes mellitus.

Career Highlights

Ueda is currently associated with Sumitomo Pharmaceuticals Company Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to finding effective treatments for serious health issues.

Collaborations

Ueda has collaborated with esteemed colleagues such as Norio Fujiwara and Shinobu Murata, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yutaka Ueda's contributions to pharmaceutical innovations demonstrate his dedication to improving healthcare through scientific research. His patents reflect a commitment to addressing critical medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…